- Home
- AUUD vs TCRT Comparison
AUUD vs TCRT Comparison
Compare AUUD & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- TCRT
- Stock Information
- Founded
- AUUD 2012
- TCRT 1998
- Country
- AUUD United States
- TCRT United States
- Employees
- AUUD N/A
- TCRT N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- TCRT Health Care
- Exchange
- AUUD Nasdaq
- TCRT Nasdaq
- Market Cap
- AUUD 2.9M
- TCRT 3.8M
- IPO Year
- AUUD 2021
- TCRT N/A
- Fundamental
- Price
- AUUD $3.72
- TCRT $2.84
- Analyst Decision
- AUUD
- TCRT
- Analyst Count
- AUUD 0
- TCRT 0
- Target Price
- AUUD N/A
- TCRT N/A
- AVG Volume (30 Days)
- AUUD 186.2K
- TCRT 49.8K
- Earning Date
- AUUD 05-20-2025
- TCRT 05-19-2025
- Dividend Yield
- AUUD N/A
- TCRT N/A
- EPS Growth
- AUUD N/A
- TCRT N/A
- EPS
- AUUD N/A
- TCRT N/A
- Revenue
- AUUD N/A
- TCRT $10,000.00
- Revenue This Year
- AUUD N/A
- TCRT $5,680,500.00
- Revenue Next Year
- AUUD N/A
- TCRT N/A
- P/E Ratio
- AUUD N/A
- TCRT N/A
- Revenue Growth
- AUUD N/A
- TCRT 100.00
- 52 Week Low
- AUUD $2.88
- TCRT $1.31
- 52 Week High
- AUUD $33.32
- TCRT $14.20
- Technical
- Relative Strength Index (RSI)
- AUUD 47.35
- TCRT 59.86
- Support Level
- AUUD $3.46
- TCRT $2.56
- Resistance Level
- AUUD $3.85
- TCRT $3.01
- Average True Range (ATR)
- AUUD 0.37
- TCRT 0.27
- MACD
- AUUD 0.09
- TCRT 0.03
- Stochastic Oscillator
- AUUD 68.50
- TCRT 98.55
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.